Rossari Biotech Limited achieved a 37.25% reduction in Scope 1 greenhouse gas (GHG) emissions during the financial year 2025-26, primarily driven by lower diesel consumption and enhanced fuel efficiency across operations. The specialty chemicals manufacturer reported progress in environmental performance metrics, including improved energy and water intensity, alongside expanded waste recycling efforts.

The company’s total energy consumption increased to 56,962.93 GigaJoules (GJ) in FY26 from 47,872.42 GJ in the previous year, attributed to higher production volumes. However, energy intensity improved to 0.556 GJ per metric tonne of aggregate (MTA) from 0.564 GJ/MTA, reflecting better operational efficiency. Renewable energy accounted for approximately 33% of total energy consumption during the year.

Water consumption rose to 1,31,406 kilolitres from 1,10,840 kilolitres, yet water intensity improved significantly to 1.08 KL/MTA from 1.55 KL/MTA. The company implemented water recycling initiatives, recovering approximately 1.665 KL of treated water for reuse. The Silvassa facility operates as a Zero Liquid Discharge (ZLD) unit.

Environmental Performance

Total waste generation increased to 3,401.35 metric tonnes from 1,696.55 metric tonnes, largely due to higher production volumes and increased hazardous waste streams. The company recycled approximately 778.14 metric tonnes of waste, including 387.57 metric tonnes of plastic waste and 246.96 metric tonnes of hazardous waste. Hazardous waste managed through pre-processing and co-processing methods increased to 246.96 metric tonnes from 45.44 metric tonnes in the previous year.

Governance and Compliance

The company reported no fines, penalties, or legal actions during the financial year. It maintained compliance with all applicable environmental regulations, including the Water Act, Air Act, and Environment Protection Act. Rossari Biotech’s Integrated Management System is certified to ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 standards.

Mr. Edward Menezes, Executive Chairman, oversees the company’s sustainability agenda. The Board of Directors reviews performance against policies, while the Audit Committee monitors grievance redressal mechanisms. The company received a score of 93% in the Together for Sustainability audit and participated in the EcoVadis sustainability assessment.

Social and Employee Welfare

The company employed 600 employees and 678 workers as of March 31, 2026. Women comprised 17.33% of the total workforce and held 33.33% of Board positions. All employees and workers received training on health and safety measures, with 100% coverage for skill upgradation programs. The company reported zero safety incidents, including no lost time injuries or fatalities, during the year.

Rossari Biotech's subsidiary Unistar Thai has established a blending facility in Thailand with an installed capacity of 5000 MTPA. The new plant is situated on a land area of approximately 1,860 square meters and is designed to function as a regional technical hub. This strategic move aims to address the growing Southeast Asian market through customized formulations tailored to local requirements.

The facility offers flexible manufacturing capabilities across powders, granules, and liquids. It is supported by dedicated storage capacity for surfactants and other key raw materials, which ensures supply chain resilience and operational efficiency. The development follows the acquisition of 100% equity share capital of Unistar Thai by Rossari Global FZCO, a wholly owned subsidiary of Rossari Biotech, on December 10, 2024.

Key Details of the New Facility

The disclosure was made to the exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Parul Gupta, Company Secretary & Head - Legal.